MSB 6.00% 94.0¢ mesoblast limited

Gilead vs Mesoblast, page-275

  1. 7,511 Posts.
    lightbulb Created with Sketch. 6768
    Absolutely,

    I never posted this original thread. I don't think its a case of MSB vs GILD. Gilead have very much moved their criteria intra and inter-trials. MSB has not. It has consistently set clear criteria for patients in the trials. Gilead has not. They have also changed the end-point. Honestly, just go the Gilead results and read them for yourself. Don't listen to me. Make your own mind up:

    https://www.gilead.com/news-and-press/press-room/press-releases/2020/4/gilead-announces-results-from-phase-3-trial-of-investigational-antiviral-remdesivir-in-patients-with-severe-covid-19

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
94.0¢
Change
-0.060(6.00%)
Mkt cap ! $1.073B
Open High Low Value Volume
99.0¢ 99.5¢ 93.5¢ $5.643M 5.894M

Buyers (Bids)

No. Vol. Price($)
14 72266 93.5¢
 

Sellers (Offers)

Price($) Vol. No.
94.5¢ 20000 1
View Market Depth
Last trade - 16.10pm 02/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.